Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-29T17:09:20.688Z Has data issue: false hasContentIssue false
  • English
  • Français

Migraine: Prevalence and Associated Disability Among Nigerian Undergraduates

Published online by Cambridge University Press:  02 December 2014

Kolawole Wasiu Wahab  and
Asuwemhe Johnson Ugheoke
Kolawole Wasiu Wahab*
Affiliation:
Division of Neurology, Department of Medicine, University of Ilorin Teaching Hospital, Ilorin
Asuwemhe Johnson Ugheoke
Affiliation:
Department of Medicine, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria
*
Division of Neurology, Department of Medicine, University of Ilorin Teaching Hospital, PMB 1459, Ilorin, 240001, Kwara State, Nigeria
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

Studies on migraine in Nigeria are scanty while the disability associated with the disease has not been determined. We aimed at determining the lifetime prevalence of migraine and its associated disability among the students of a Nigerian university.

Method:

Using a multi-stage sampling method, undergraduates of Ambrose Alli University, Nigeria were screened with the International Headache Society (IHS) criteria. Those who satisfied the criteria for migraine were then assessed with the Migraine Disability Assessment questionnaire to ascertain the level of disability resulting from migraine in the three months preceding the study. Information was also obtained on the use of preventive and abortive medications.

Results:

Out of the 1513 respondents screened, 145 satisfied the IHS criteria for the diagnosis of migraine giving an overall lifetime prevalence of 9.6% (females 10.3%, males 8.9%, p>0.05). Migraine associated disability was little or none in 53.1% (males 55.2%, females 51.3%, p>0.05), mild in 10.3% (males 11.9%, females 9.0%, p>0.05), moderate in 20.7% (males 20.9%, females 20.5%, p>0.05) and severe in 15.9% (males 11.9%, females 19.2%, p>0.05). In spite of the fact that 53 (36.6%) of the migraineurs had moderate-severe disability, only 19/53 (35.8%) reported being on preventive treatment while none had ever used a triptan.

Conclusion:

Prevalence of migraine among our respondents falls within the range reported from similar studies among university students outside Africa. In spite of the high disability associated with the disease, use of effective preventive and abortive therapies is very poor.

Type
Original Article
Information
Canadian Journal of Neurological Sciences , Volume 36 , Issue 2 , March 2009 , pp. 216 - 221
Copyright
Copyright © The Canadian Journal of Neurological 2009

References

1.Menken, M, Munsat, TL, Toole, JF.The global burden of disease study implications for neurology. Arch Neurol. 2000; 57: 418–20.Google Scholar
2.Osuntokun, BO, Adeuja, AO, Nottidge, VA, Bademosi, O, Alumide, AO, Ige, O, et al.Prevalence of headache and migrainous headache among Nigerian Africans: a community-based study. East Afr Med J. 1992; 69(4): 196–9.Google Scholar
3.Stewart, WF, Lipton, RB, Celentano, DD, Reed, MI.Prevalence of migraine headache in the United States: relation to age, income, race and other sociodemographic factors. JAMA. 1992; 267: 64–9.CrossRefGoogle ScholarPubMed
4.Rasmussen, BK, Olesen, J.Symptomatic and nonsymptomatic headaches in a general population. Neurology. 1992; 42: 1225–31.CrossRefGoogle ScholarPubMed
5.Steiner, TJ, Stewart, WF, Kolodner, K, Liberman, J, Lipton, RB.Epidemiology of migraine in England. Cephalalgia. 1999; 19: 3305–6. [abstract].Google Scholar
6.Pryse-Phillips, W, Findlay, H, Tugwell, P, Edmeads, J, Murray, TJ, Nelson, RF.A Canadian population survey on the clinical, epidemiologic and societal impact of migraine and tension-type headache. Can J Neurol Sci. 1992; 19 (3): 333–9.Google Scholar
7.Mitsikostas, DD, Gatzonis, S, Thomas, A, Kalfakis, N, Ilias, A, Papageoergiou, C.An epidemiological study of headaches among medical students in Athens. Headache. 1996; 36: 561–4.Google Scholar
8.Sanvito, WL, Monzillo, PH, Peres, MF, Martinelli, MO, Fera, MP, Gouveia, DA, et al.The epidemiology of migraine in medical students. Headache. 1996; 36: 316–9.Google Scholar
9.Lipton, RB, Stewart, WF, Stone, AM, Lainez, MJA, Sawyer, JPC.Stratified care versus step care strategies for migraine. JAMA. 2000; 284: 2599–605.CrossRefGoogle Scholar
10.Lipton, RB, Silberstein, SD.The role of headache-related disability in migraine management: implications for headache treatment guidelines. Neurology. 2001; 56: 35–42.Google Scholar
11.Oluwole, S, Bwala, SA, Nwabueze, AC, Davies, AO.Effectiveness of sumatriptan for acute treatment of migraine headache in an African population. Afr J Neurol Sci. 2003; 22(2). Available from: http://www.ajol.info. [cited 2008 Jan 7]. http://www.ajol.infoGoogle Scholar
12.World Health Organization Teaching Statistics. In: Lwanga, SK, Tye, CY, editors. Twenty lessons and seminar outlines. Geneva WHO. 1986. p. 67–74.Google Scholar
13.Ogunyemi, AO.Prevalence of headache among Nigerian university students. Headache. 1984; 24: 127–30.CrossRefGoogle ScholarPubMed
14.Headache Classification Committee of the International Headache Society. The international classification of headache disorders. (2nd ed.). Cephalalgia. 2004; 24 suppl 1: 1–160.Google Scholar
15.Stewart, WF, Lipton, RB, Kolodner, K, Liberman, J, Sawyer, J.Reliability of the Migraine Disability Assessment score in a population-based sample of headache sufferers. Cephalalgia. 1999; 19: 107–14.Google Scholar
16.Bener, A.Frequency of headache and migraine in Qatar. Neuro-epidemiology. 2006; 27(2): 61–6.Google Scholar
17.Deleu, D, Khan, MA, Humaidan, H, Al Mantheri, Z, Al Hashami, S.Prevalence and clinical characteristics of headache in medical students in Oman. Headache. 2001; 41 (8): 798–804.Google Scholar
18.Demirkirkan, MK, Ellidokuz, H, Boluk, A.Prevalence and clinical characteristics of migraine in university students in Turkey. Tohoku J Exp Med. 2006; 208: 87–92.Google Scholar
19.O’Brien, B, Goeree, R, Streiner, D.Prevalence of migraine headache in Canada: a population-based survey. Int J Epidemiol. 1994; 23 (5): 1020–6.Google Scholar
20.Ad Hoc Committee: Classification of Headache. JAMA. 1962; 179: 717–18.Google Scholar
21.MacGregor, EA, Brandes, J, Eikermann, A.Migraine prevalence and treatment patterns: the global migraine and zolmitriptan evaluation survey. Headache. 2003; 43: 19–26.Google Scholar
22.Jelinski, SE, Becker, WJ, Christie, SN, Giammarco, R, Mackie, GF, Gawel, MJ, et al.Clinical features and pharmacological treatment of migraine patients referred to headache specialists in Canada. Cephalalgia. 2005; 26: 578–88.Google Scholar